Arthur Hayes Shifts Focus to Longevity: Transitioning from Derivatives to Stem Cells and DeSci

Arthur Hayes, the billionaire co-founder of BitMEX, is redirecting his focus from perpetual swaps to everlasting life as the crypto market specialist concentrates on longevity science for significant growth.

Recently pardoned by Donald Trump in March, which annulled his conviction for violations of the Bank Secrecy Act, Hayes has secured a position on the board and a substantial equity share in a stem cell company where he has also received treatment.

Hayes informed reporters that he has been receiving treatments at the firm’s clinics in Mexico and Bangkok for over a year, highlighting his personal belief in the longevity field.

“I aim to live as long as possible, as healthily as possible,” he remarked, pointing out that regulatory obstacles surrounding stem cell therapies are diminishing in various nations. The company, currently undergoing a rebranding, has yet to be disclosed.

First Vitalik, Now Hayes: Crypto Wealth Channels Into Longevity

Hayes isn’t the only one. An increasing number of crypto asset leaders are reallocating the fortunes they’ve amassed in digital assets toward life-extension initiatives:

Vitalik Buterin has contributed to the SENS Research Foundation and initiated the Zuzalu “pop-up city” project in 2023 to nurture innovative methods for combating aging.

Brian Armstrong, Coinbase’s CEO, co-founded NewLimit, a cellular reprogramming startup that secured $130 million this year.

Balaji Srinivasan, former CTO of Coinbase, co-founded Counsyl, a genomics enterprise that pioneered cost-effective screening for hereditary conditions.

This convergence of crypto asset and longevity mirrors a broader belief that both domains share: dismantling established systems, whether in financial structures or biological certainties.

DISCOVER: The 12+ Hottest Crypto Presales to Buy Right Now

DeSci and the Emergence of BIO Protocol: Is Decentralized Funding The Solution?

Hayes’ transition also coincides with a resurgence in decentralized science (DeSci), where blockchain-based funding models are revitalizing biomedical research previously starved of resources.

Bio Protocol (BIO), the foremost DeSci crypto token, has recently experienced a 13% increase following its listing on Bithumb, adding to the momentum gained from its earlier inclusion on Binance and Ethereum-based earning yield systems.

BIO’s framework enables researchers and patients to collaborate through BioDAOs, offering direct funding for initiatives like rare disease trials or brain health research that traditional funding mechanisms often overlook.

Tokenomics intertwine utility and outcomes: the intellectual property generated via BioDAOs can yield royalties for coin holders, creating a closed-loop incentive system absent in standard scientific funding.

Projects like VitaDAO and Armstrong-supported RSC are already directing millions into longevity research, while on-chain “BioAgents” leverage AI simulations to create and tokenize hypotheses, transforming lab concepts into tradable intellectual property.

DISCOVER: Best New Cryptocurrencies to Invest in 2025

From Perpetual Swaps to Eternal Life

Hayes’ fund, Maelstrom, continues to bolster open-source Bitcoin development and digital asset treasuries, yet his shift points to a larger trend: the early billionaires of crypto no longer seek merely to alter markets; they aspire to transform mortality itself.

With over $800M in cumulative revenues already flowing through DeSci platforms like Pump.fun and BIO gaining momentum across Asian exchanges, the financial frameworks are starting to align with scientific aspirations.

For Hayes, the forthcoming major investment may not hinge on trading market dynamics but rather on biological ones. Just as BitMEX once set the standard for crypto derivatives, his involvement in longevity could establish the DeSci space as the next trillion-dollar convergence of blockchain and science.

DISCOVER: 9+ Best High-Risk, High-Reward Crypto to Buy in 2025

The post Arthur Hayes Turns to Longevity: From Derivatives to Stem Cells and DeSci appeared first on 99Bitcoins.